Clinical Trials Directory

Trials / Completed

CompletedNCT04625465

Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
474 (actual)
Sponsor
Georgia State University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

We will recruit sexual and gender minority couples to complete 56 days of daily surveys in order to evaluate (1) the impact of COVID-19 stress and sexual and gender minority stress on heavy episodic drinking and intimate partner violence (IPV) perpetration, and (2) a brief, mobile-phone delivered text messaging intervention to mitigate the effects of these stressors. This project has high potential to inform how pandemic stress contributes to etiological models of alcohol-related IPV perpetration in sexual and gender minority couples and inform a culturally-sensitive, low burden, and easy to disseminate intervention to mitigate these effects critical during a pandemic when access to care is limited.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCBT Text MessagingOver a 14 day period, participants will receive two text messages per day (one at 8 a.m. and one at 4 p.m.). They will receive hourly reminders for four hours or until the message is read. Participants receive the same messages in the same order, with content equally distributed across the four content areas (i.e., psychoeducation regarding effects of stress, distress tolerance, emotion regulation, alcohol reduction).
BEHAVIORALAttention Control Text MessagingOver a 14 day period, participants will receive two text messages per day (one at 8 a.m. and one at 4 p.m.). They will receive hourly reminders for four hours or until the message is read. Participants receive the same messages in the same order. All texts will be supportive messages which express empathy and unconditional positive regard and provide support for dealing with stressors. These messages will be nondirective and will not include any CBT skill suggestions.

Timeline

Start date
2020-11-12
Primary completion
2023-12-15
Completion
2023-12-15
First posted
2020-11-12
Last updated
2025-07-14
Results posted
2025-07-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04625465. Inclusion in this directory is not an endorsement.